Finder makes money from featured partners, but editorial opinions are our own.

How to buy Evotec SE stock in Canada

Own Evotec SE shares in just a few minutes.

Evotec SE is a drug manufacturers - specialty & generic business based in the US. Evotec SE shares (EVO.US) are listed on the NASDAQ and all prices are listed in US dollars. Its last market close was $5.14 – a decrease of 1.15% over the previous day. Evotec SE employs 5,061 staff and has a trailing 12-month revenue of around $781.4 million.

How to buy shares in Evotec SE

Choose a platform. If you're a beginner, our stock trading platform picks below can help you choose.
Open your account. Provide your personal information and sign up.
Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
Search the platform for stock code: EVO in this case.
Research stocks. The platform should provide the latest information available.
Buy your stocks. Place a market order or limit order with your preferred number of shares. It's that simple.

The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Go to site

Low margin rates

Access to international stock exchanges
Low margin rates
Powerful research tools

Go to site

CA & US trading

Up to $2,400 cash reward
Low transaction fees
Easy-to-use app

Go to site

Free trades for young investors

Easy-to-use platform
Low fees
Student and young investor discounts

Our selection of top picks is based on the same criteria as our annual Stock Trading Platform Awards. This is updated yearly to reflect changes in the market.

"Best for" picks are those we've evaluated to be best for specific product features or categories – you can read our full methodology here. If we show a "Promoted" pick, it's been chosen from among our commercial partners and is based on factors that include special features or offers, and the commission we receive.

This isn't an exhaustive list of all the trading platforms out there. What's best for you depends on your own investing strategy, budget and financial goals.

Is it a good time to buy Evotec SE stock?

Only you can make the decision on the time to leap... but here's some supporting information and analysis.

Use our graph to track the performance of EVO stocks over time.

Share price volatility

Over the last 12 months, Evotec SE's shares have ranged in value from as little as $4.8701 up to $13.4924. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Evotec SE's is 1.105. This would suggest that Evotec SE's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Historical closes compared with the last close of $5.14

1 week (2024-05-01)	-4.28%
1 month (2024-04-08)	-34.36%
3 months (2024-02-08)	-31.83%
6 months (2023-11-08)	-46.68%
1 year (2023-05-08)	-45.03%
2 years (2022-05-08)	-52.32%
3 years (2021-05-06)	-93.68%
5 years (2019-05-07)	-89.75%

The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Is Evotec SE under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Evotec SE P/E ratio, PEG ratio and EBITDA

Evotec SE EBITDA

Evotec SE's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $72.1 million ($99 million CAD).

The EBITDA is a measure of a Evotec SE's overall financial performance and is widely used to measure a its profitability.

Frequently asked questions

Evotec SE's shares were split on a 4:1 basis on 19 October 2021. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Evotec SE shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for Evotec SE shares which in turn could have impacted Evotec SE's share price.
It's as easy to sell Evotec SE as it is to buy! Here's how to sell Evotec SE stocks that you already own.
1. Open your investment app. If you've got one with desktop access, you can log in online
2. Go to your portfolio. This should be in the main menu
3. Find your shares. You may be able to search your portfolio
4. Choose how many you'd like to sell. You'll be able to review the price and see how much you'll receive
5. Sell your Evotec SE shares. Your investment platform will let you know when your shares are sold

Evotec SE financials

Revenue TTM	$781.4 million
Operating margin TTM	15.81%
Gross profit TTM	$151.5 million
Return on assets TTM	0.03%
Return on equity TTM	-7.27%
Profit margin	-10.74%
Book value	$6.33
Market capitalisation	$1.9 billion

TTM: trailing 12 months

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.